Neurothera Labs Inc.
NTLX.V
TSX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | -10.38% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | -10.38% | |||
| Cost of Revenue | 0.00% | -33.33% | |||
| Gross Profit | 0.00% | 1.43% | |||
| SG&A Expenses | 0.00% | -5.86% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | -52.15% | |||
| Operating Income | 0.00% | 54.83% | |||
| Income Before Tax | 0.00% | 73.16% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.00% | 73.29% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | -86.04% | |||
| Net Income | 0.00% | 72.49% | |||
| EBIT | 0.00% | 54.83% | |||
| EBITDA | 0.00% | 55.65% | |||
| EPS Basic | 0.00% | 75.09% | |||
| Normalized Basic EPS | 0.00% | 73.67% | |||
| EPS Diluted | 0.00% | 75.09% | |||
| Normalized Diluted EPS | 0.00% | 73.67% | |||
| Average Basic Shares Outstanding | 0.00% | 10.44% | |||
| Average Diluted Shares Outstanding | 0.00% | 10.44% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||